A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Paliperidone Palmitate in Patients With Schizophrenia
Status:
Completed
Trial end date:
2014-05-24
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the pharmacokinetics, safety, and tolerability of a
paliperidone palmitate 3-month formulation in patients with schizophrenia.